StockData
Eloxx Pharmaceuticals, Inc. logo

Eloxx Pharmaceuticals, Inc. (ELOX) stock

ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$11.74−1.01 (-7.92%)

Close on Nov 17, 2026Market cap $79.70MP/E –Yield –

Eloxx Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Eloxx Pharmaceuticals's cash was $61.96M at Jun 30, 2026. For fiscal 2025 it was $4.79M, up 4210.8% from the year before. Over ten years it grew -2.4% a year on average. The highest annual figure on record is $56.28M in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.79M+4210.8%
FY2024Dec 31, 2024$111.00K-90.2%
FY2023Dec 31, 2023$1.13M-94.1%
FY2022Dec 31, 2022$19.21M-54.6%
FY2021Dec 31, 2021$42.27M+71.3%
FY2020Dec 31, 2020$24.67M-56.2%
FY2019Dec 31, 2019$56.28M+15.8%
FY2018Dec 31, 2018$48.61M+5894.8%
FY2016Jun 30, 2016$810.81K-75.7%
FY2015Jun 30, 2015$3.33M-45.4%
FY2014Jun 30, 2014$6.11M+281.4%
FY2013Jun 30, 2013$1.60M-19.9%
FY2012Jun 30, 2012$2.00M-44.6%
FY2011Jun 30, 2011$3.61M-55.0%
FY2010Jun 30, 2010$8.03M+2009.0%
FY2009Jun 30, 2009$380.57K–
FY1998Jun 30, 1998$0–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$61.96M+13668.9%
Q1 FY2026CQ1 2026Mar 31, 2026$6.36M+5632.4%
Q4 FY2025CQ4 2025Dec 31, 2025$4.79M+322.0%
Q2 FY2025CQ2 2025Jun 30, 2025$572.00K-88.0%
Q1 FY2025CQ1 2025Mar 31, 2025$450.00K-89.6%
Q4 FY2024CQ4 2024Dec 31, 2024$111.00K-97.7%
Q4 FY2023CQ4 2023Dec 31, 2023$1.13M-94.1%
Q3 FY2023CQ3 2023Sep 30, 2023$4.78M-80.6%
Q2 FY2023CQ2 2023Jun 30, 2023$4.33M-85.6%
Q1 FY2023CQ1 2023Mar 31, 2023$4.90M-87.7%
Q4 FY2022CQ4 2022Dec 31, 2022$19.21M-54.6%
Q3 FY2022CQ3 2022Sep 30, 2022$24.55M-53.2%
Q2 FY2022CQ2 2022Jun 30, 2022$30.05M-47.0%
Q1 FY2022CQ1 2022Mar 31, 2022$39.77M+117.9%
Q4 FY2021CQ4 2021Dec 31, 2021$42.27M+71.3%
Q3 FY2021CQ3 2021Sep 30, 2021$52.43M+71.4%
Q2 FY2021CQ2 2021Jun 30, 2021$56.73M+52.9%
Q1 FY2021CQ1 2021Mar 31, 2021$18.25M-58.5%
Q4 FY2020CQ4 2020Dec 31, 2020$24.67M-56.2%
Q3 FY2020CQ3 2020Sep 30, 2020$30.59M-52.9%
Q2 FY2020CQ2 2020Jun 30, 2020$37.12M-51.4%
Q1 FY2020CQ1 2020Mar 31, 2020$43.96M-17.8%
Q4 FY2019CQ4 2019Dec 31, 2019$56.28M+15.8%
Q3 FY2019CQ3 2019Sep 30, 2019$64.94M+17.3%
Q2 FY2019CQ2 2019Jun 30, 2019$76.30M+20.3%
Q1 FY2019CQ1 2019Mar 31, 2019$53.50M+192.5%
Q4 FY2018CQ4 2018Dec 31, 2018$48.61M+5894.8%
Q3 FY2018CQ3 2018Sep 30, 2018$55.34M+3527.2%
Q2 FY2018CQ2 2018Jun 30, 2018$63.41M+4528.6%
Q1 FY2018CQ1 2018Mar 31, 2018$18.29M+445.2%
Q4 FY2016CQ2 2016Jun 30, 2016$810.81K-75.7%
Q3 FY2016CQ1 2016Mar 31, 2016$1.53M+224.6%
Q2 FY2016CQ4 2015Dec 31, 2015$1.37M-21.1%
Q1 FY2016CQ3 2015Sep 30, 2015$3.35M-12.6%
Q4 FY2015CQ2 2015Jun 30, 2015$3.33M-45.4%
Q3 FY2015CQ1 2015Mar 31, 2015$469.98K-92.4%
Q2 FY2015CQ4 2014Dec 31, 2014$1.74M–
Q1 FY2015CQ3 2014Sep 30, 2014$3.84M–
Q4 FY2014CQ2 2014Jun 30, 2014$6.11M–
Q3 FY2014CQ1 2014Mar 31, 2014$6.20M–

More Eloxx Pharmaceuticals figures

See a number that looks wrong?